NASDAQ:ODT

Odonate Therapeutics, Inc.

Stock

USD

Last Close

1.17

01/01 00:00

Volume Today

716.44K

Avg: 959.82K

PE Ratio

−0.29

PFCF: -

Overview Analysis Financials Filings people API Chart Data

locale
United States
market
STOCKS
industry
Biotechnology
website
www.odonate.com
ipo date
Dec 07, 2017

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

Excel Tearsheet

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

*Estimate based on analyst consensus